St. Page et al., DIFFERENTIAL CONTRIBUTION OF LCK AND FYN PROTEIN-TYROSINE KINASES TO INTRAEPITHELIAL LYMPHOCYTE DEVELOPMENT, European Journal of Immunology, 27(2), 1997, pp. 554-562
The developmental stages and the role of protein tyrosine kinases (PTK
) in the maturation of CD3(+)CD8 alpha alpha(+) intraepithelial lympho
cytes (IEL) have not been extensively characterized. However, comparis
ons of thymic and extrathymic T cell development indicate that these p
rocesses involve some distinct signaling and selection events. We used
mice deficient in Lck, Fyn, or both Lck and Fyn to analyze the role t
hat these src-family PTK play in IEL development. In contrast to thymo
cyte development, we found that all IEL subsets develop in mice defici
ent for either kinase alone. However, lck(-/-) animals exhibited reduc
ed numbers of TcR alpha beta(+)CD8 alpha alpha(+) IEL, indicating that
Lck is important in the development of these cells. Mice which lack b
oth Lck and Fyn fail to generate TcR alpha beta(+) IEL, suggesting tha
t signaling through the preTcR, mediated by Lck and, to a lesser exten
t Fyn, is required for maturation of all TcR alpha beta(+) IEL lineage
s. Interestingly, a small population of TcR gamma delta(+)CD8 alpha al
pha(+) cells are apparent in lck(-/-)fyn(-/-) animals, demonstrating t
hat TcR alpha beta(+)CD8 alpha alpha(+) and TcR gamma delta(+)CD8 alph
a alpha(+) IEL have distinct PTK requirements for their development or
expansion. CD3(-)-CD8 alpha(-)CD44(+) and CD3(-)CD8 alpha alpha(+)CD1
6/32(+)B220(+) cells comprise the majority of IEL in both lck(-/-)fyn(
-/-) and rag(-/-) mice, while they are poorly represented in wild-type
controls. Comparison of the cell surface phenotype of these putative
precursor IEL in lck(-/-)fyn(-/-) and rag(-/-) animals suggests that I
EL maturation in these animals is arrested at an equivalent developmen
tal stage. Overall, the data presented demonstrate that signals mediat
ed by Lck or Fyn direct TcR alpha beta(+)CD8 alpha alpha(+) IEL matura
tion but are dispensable for the development of TcR gamma delta(+)CD8
alpha alpha(+) IEL.